213 related articles for article (PubMed ID: 9041231)
1. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
Eissele R; Brunner G; Simon B; Solcia E; Arnold R
Gastroenterology; 1997 Mar; 112(3):707-17. PubMed ID: 9041231
[TBL] [Abstract][Full Text] [Related]
2. [Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa. Preliminary results].
Cadiot G; Vissuzaine C; Pospai D; Ruszniewski P; Potet F; Mignon M
Gastroenterol Clin Biol; 1995 Oct; 19(10):811-7. PubMed ID: 8566561
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
Rindi G; Fiocca R; Morocutti A; Jacobs A; Miller N; Thjodleifsson B;
Eur J Gastroenterol Hepatol; 2005 May; 17(5):559-66. PubMed ID: 15827447
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
Berstad AE; Hatlebakk JG; Maartmann-Moe H; Berstad A; Brandtzaeg P
Gut; 1997 Dec; 41(6):740-7. PubMed ID: 9462205
[TBL] [Abstract][Full Text] [Related]
6. Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.
Geboes K; Dekker W; Mulder CJ; Nusteling K;
Aliment Pharmacol Ther; 2001 Nov; 15(11):1819-26. PubMed ID: 11683696
[TBL] [Abstract][Full Text] [Related]
7. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
Aliment Pharmacol Ther; 2002 Jan; 16(1):159-65. PubMed ID: 11856091
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
Arroyo Villarino MT; Lanas Arbeloa A; Esteva Díaz F; Ortego Fernández de Retana J; Sainz Samitier R
Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140
[TBL] [Abstract][Full Text] [Related]
10. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
Stolte M; Meining A; Schmitz JM; Alexandridis T; Seifert E
Aliment Pharmacol Ther; 1998 Mar; 12(3):247-53. PubMed ID: 9570259
[TBL] [Abstract][Full Text] [Related]
11. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
Lamberts R
Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
[TBL] [Abstract][Full Text] [Related]
12. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
Chuang CH; Sheu BS; Yang HB; Kao AW; Cheng HC; Yao WJ
J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
[TBL] [Abstract][Full Text] [Related]
13. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
Meining A; Kiel G; Stolte M
Aliment Pharmacol Ther; 1998 Aug; 12(8):735-40. PubMed ID: 9726386
[TBL] [Abstract][Full Text] [Related]
14. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.
Lamberts R; Brunner G; Solcia E
Digestion; 2001; 64(4):205-13. PubMed ID: 11842276
[TBL] [Abstract][Full Text] [Related]
15. Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors.
Hirschowitz BI; Simmons J; Mohnen J
Aliment Pharmacol Ther; 2002 Feb; 16(2):303-13. PubMed ID: 11860414
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.
Diebold MD; Richardson S; Duchateau A; Bigard MA; Colin R; Cortot A; Fauchère JL; Zeitoun P
Dig Dis Sci; 1998 Aug; 43(8):1629-35. PubMed ID: 9724142
[TBL] [Abstract][Full Text] [Related]
17. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
18. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.
Lamberts R; Creutzfeldt W; Strüber HG; Brunner G; Solcia E
Gastroenterology; 1993 May; 104(5):1356-70. PubMed ID: 8482449
[TBL] [Abstract][Full Text] [Related]
19. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
Creutzfeldt W; Lamberts R
Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
